Literature DB >> 8731670

Expression of CD44 isoforms in basal cell carcinomas.

H P Baum1, T Schmid, G Schock, J Reichrath.   

Abstract

The expression of CD44 isoforms (CD44std, CD44v6, CD44v10) was investigated by an immunohistochemical technique in 42 basal cell carcinomas (BCC) of the superficial and nodular variety. All BCCs studied displayed very low amounts of CD44std, a receptor for hyaluronic acid. Except for single CD44std-positive cells located preferentially in the central parts of the BCC nests, the bulk of the tumour formations were CD44std-negative. CD44v6 showed a heterogeneous distribution pattern accentuated in the peripheral palisading tumour cells. In superficial BCCs, the labelling intensity for CD44v6 increased with the size of the tumour nests. CD44v10 was not detectable in BCCs. Our findings support the notion that CD44v6 is not linked to the metastatic proclivity of tumours originating from keratinocytes. We suggest that the very low expression of the receptor for hyaluronic acid (CD44std) may be one of the factors which block the formation of metastases from BCCs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8731670

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

Review 1.  Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.

Authors:  Rafaela-Maria Kavasi; Monica Neagu; Carolina Constantin; Adriana Munteanu; Mihaela Surcel; Aristidis Tsatsakis; George N Tzanakakis; Dragana Nikitovic
Journal:  Front Med (Lausanne)       Date:  2022-04-29

2.  Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.

Authors:  Lorraine O'Driscoll; Jason McMorrow; Padraig Doolan; Eadaoin McKiernan; Jai Prakash Mehta; Eoin Ryan; Patrick Gammell; Helena Joyce; Norma O'Donovan; Nicholas Walsh; Martin Clynes
Journal:  Mol Cancer       Date:  2006-12-15       Impact factor: 27.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.